These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1145 related articles for article (PubMed ID: 26096858)
1. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients. Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858 [TBL] [Abstract][Full Text] [Related]
2. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD. Farah R; Ibrahim R; Nassar M; Najib D; Zivony Y; Eshel E Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443 [TBL] [Abstract][Full Text] [Related]
3. Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study. Cai C; Zeng W; Wang H; Ren S Int J Chron Obstruct Pulmon Dis; 2024; 19():933-943. PubMed ID: 38646605 [TBL] [Abstract][Full Text] [Related]
4. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker. Acartürk Tunçay E; Karakurt Z; Aksoy E; Saltürk C; Gungor S; Ciftaslan N; Irmak İ; Yavuz D; Ocakli B; Adıgüzel N Int J Chron Obstruct Pulmon Dis; 2017; 12():3361-3370. PubMed ID: 29200843 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study. Lee SJ; Lee HR; Lee TW; Ju S; Lim S; Go SI; You JW; Cho YJ; Lee GW; Jeong YY; Kim HC; Lee JD Korean J Intern Med; 2016 Sep; 31(5):891-8. PubMed ID: 27017385 [TBL] [Abstract][Full Text] [Related]
6. Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes. Aksoy E; Karakurt Z; Gungor S; Ocakli B; Ozmen İ; Yildirim E; Tuncay E; Agca MC; Ciftaslan Goksenoglu N; Adigüzel N Int J Chron Obstruct Pulmon Dis; 2018; 13():2721-2730. PubMed ID: 30233162 [TBL] [Abstract][Full Text] [Related]
7. The Importance of Neutrophil-to-Lymphocyte Ratio in Chronic Obstructive Pulmonary Disease. İn E; Kuluöztürk M; Öner Ö; Deveci F Turk Thorac J; 2016 Apr; 17(2):41-46. PubMed ID: 29404122 [TBL] [Abstract][Full Text] [Related]
8. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia. Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709 [TBL] [Abstract][Full Text] [Related]
9. The Neutrophil to Lymphocyte Ratio Is Related to Disease Severity and Exacerbation in Patients with Chronic Obstructive Pulmonary Disease. Furutate R; Ishii T; Motegi T; Hattori K; Kusunoki Y; Gemma A; Kida K Intern Med; 2016; 55(3):223-9. PubMed ID: 26831014 [TBL] [Abstract][Full Text] [Related]
10. The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation. Agapakis DI; Massa EV; Hantzis I; Maraslis S; Alexiou E; Imprialos KP; Damianidou M; Satsoglou E Respir Care; 2016 Jan; 61(1):44-9. PubMed ID: 26604328 [TBL] [Abstract][Full Text] [Related]
11. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD. Yao C; Liu X; Tang Z Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856 [TBL] [Abstract][Full Text] [Related]
12. Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients. Sakurai K; Chubachi S; Irie H; Tsutsumi A; Kameyama N; Kamatani T; Koh H; Terashima T; Nakamura H; Asano K; Betsuyaku T BMC Pulm Med; 2018 May; 18(1):65. PubMed ID: 29720140 [TBL] [Abstract][Full Text] [Related]
13. Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review. Pascual-González Y; López-Sánchez M; Dorca J; Santos S Int J Chron Obstruct Pulmon Dis; 2018; 13():3651-3662. PubMed ID: 30464448 [TBL] [Abstract][Full Text] [Related]
14. Does eosinophilia and neutrophil to lymphocyte ratio affect hospital re-admission in cases of COPD exacerbation? Çoban Ağca M; Aksoy E; Duman D; Özmen İ; Yıldırım E; Güngör S; Durmuş N; Aka Aktürk Ü; Saltürk C; Tepetam FM; Karakurt Z Tuberk Toraks; 2017 Dec; 65(4):282-290. PubMed ID: 29631526 [TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Günay E; Sarınç Ulaşlı S; Akar O; Ahsen A; Günay S; Koyuncu T; Unlü M Inflammation; 2014 Apr; 37(2):374-80. PubMed ID: 24078279 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients. El-Gazzar AG; Kamel MH; Elbahnasy OKM; El-Naggar ME Expert Rev Respir Med; 2020 Jan; 14(1):111-116. PubMed ID: 31577911 [No Abstract] [Full Text] [Related]
17. The correlational study about neutrophil-to-lymphocyte ratio and exercise tolerance of chronic obstructive pulmonary disease patients. Yuan L; Li L; Yu T; Yang Z; Jiang T; Ma Q; Qi J; Shi Y; Zhao P Medicine (Baltimore); 2020 Aug; 99(33):e21550. PubMed ID: 32872002 [TBL] [Abstract][Full Text] [Related]
18. Can we predict the prognosis of COPD with a routine blood test? Xiong W; Xu M; Zhao Y; Wu X; Pudasaini B; Liu JM Int J Chron Obstruct Pulmon Dis; 2017; 12():615-625. PubMed ID: 28243079 [TBL] [Abstract][Full Text] [Related]
19. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis. Chandrashekara S; Mukhtar Ahmad M; Renuka P; Anupama KR; Renuka K Int J Rheum Dis; 2017 Oct; 20(10):1457-1467. PubMed ID: 28952205 [TBL] [Abstract][Full Text] [Related]
20. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]